Heat Biologics Surges On Patent Filing
Heat Biologics Inc. (NASDAQ: HTBX) shares traded higher Thursday after the company filed for a patent titled “GP96-Based Cancer Therapy.” The stock was trending on StockTwits throughout the day and is likely also moving as retail traders push the stock higher.